Product Information
METOPROLOL SUCC ER 100 MG TAB is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0966 per EA under NDC 75834029205. Its NADAC has been published 144 times since Oct 25, 2023.
FDA first approved this application on Mar 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834029205
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA203699FDA Approved
3/30/2020
TE Code
AB
On Market Since
2/26/2021
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 100 MG TAB has been published 144 times since Oct 25, 2023, and over the history we have for it it has declined 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0966 per EA |
|---|---|
| All-time high | $0.1552 (Apr 10, 2024) |
| All-time low | $0.0813 (Apr 22, 2026) |
| 52-week high | $0.0998 |
| 52-week low | $0.0813 |
| Median price | $0.1005 |
| Average price | $0.1042 |
| Largest weekly change | +47.2% (Mar 20, 2024) |
| Weeks tracked | 144 |
| Tracking since | Oct 25, 2023 |
1W
N/A
1M
N/A
3M
+12.3%
6M
+17.5%
1Y
-3.2%
3Y
N/A
5Y
N/A
All
-27.6%
Last surveyed Jul 22, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 100 MG TAB, manufactured by Nivagen Pharmaceuticals Inc., is $0.0966 per EA (NDC 75834029205), effective Jul 22, 2026.
How has the price of METOPROLOL SUCC ER 100 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 100 MG TAB has declined 27.6%. It has been tracked across 144 weekly CMS publications since Oct 25, 2023.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 100 MG TAB?
Since Oct 25, 2023, the NADAC for METOPROLOL SUCC ER 100 MG TAB has ranged from a low of $0.0813 (Apr 22, 2026) to a high of $0.1552 (Apr 10, 2024), with a median of $0.1005 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 100 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 100 MG TAB, is $0.0822 per EA — about 15% below METOPROLOL SUCC ER 100 MG TAB.
Who manufactures METOPROLOL SUCC ER 100 MG TAB?
METOPROLOL SUCC ER 100 MG TAB (NDC 75834029205) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.